"Treatment Use of ECMO In Pregnancy or Peripartum Patient."

The goal of this study is to describe the use of ECMO (Extracorporeal Membrane Oxygenation) in the pregnant or peripartum patient.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cardiogenic Shock Cardiomyopathies Cardiovascular Diseases Complication, Pregnancy Female Urogenital Diseases and Pregnancy Complications Heart Diseases Infarction Ischemia Myocardial Infarction Myocardial Ischemia Necrosis Pathologic Processes Pathological Conditions, Signs and Symptoms Peripartum Cardiomyopathy Pregnancy Complications Pregnancy Complications, Cardiovascular Shock Shock, Cardiogenic Urogenital Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Medical College of Wisconsin

Milwaukee, Wisconsin, 53226, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Female
Age 18 years or greater at the time of ECMO treatment.
Pregnant or within 6 months post-partum at the time of ECMO cannulation

Exclusion criteria

No history of pregnancy.
No treatment with ECMO.

Treatment and study plan

Extracorporeal membrane oxygenation

Device

Use of ECMO for circulatory / hemodynamic support of peripartum of pregnant patients who developed cardiogenic shock.

Primary outcomes

Clinical Outcome of Mother

Time frame: Time of diagnosis -Six Month Survival Rate

Describe clinical course of pregnant or recently postpartum patients with cardiogenic shock treated with ECMO, including the rate of neonate survival

Sponsors and collaborators

Lead sponsor

Sarah Thordsen

Other

Collaborators

Medical College of Wisconsin

Registry information

Important dates

Study start: 2019
Primary completion: 2020
Study completion: 2020
First posted: Oct 30, 2019
Registry last updated: Nov 23, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed